| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Singh, B. P., et al.
(author)
-
Experimental access to Transition Distribution Amplitudes with the PANDA experiment at FAIR
- 2015
-
In: European Physical Journal A. Hadrons and Nuclei. - : Springer Science and Business Media LLC. - 1434-6001 .- 1434-601X. ; 51:8
-
Journal article (peer-reviewed)abstract
- Baryon-to-meson Transition Distribution Amplitudes (TDAs) encoding valuable new information on hadron structure appear as building blocks in the collinear factorized description for several types of hard exclusive reactions. In this paper, we address the possibility of accessing nucleon-to-pion (pi N) TDAs from (p) over barp -> e(+)e(-)pi(0) reaction with the future PANDA detector at the FAIR facility. At high center-of-mass energy and high invariant mass squared of the lepton pair q(2), the amplitude of the signal channel (p) over barp -> e(+)e(-)pi(0) admits a QCD factorized description in terms of pi N TDAs and nucleon Distribution Amplitudes (DAs) in the forward aid backward kinematic regimes. Assuming the validity of this factorized description, we perform feasibility studies for measuring (p) over barp -> e(+)e(-)pi(0) with the PANDA detector. Detailed simulations on signal reconstruction efficiency as well as on rejection of the most severe background channel, i.e. (p) over barp -> pi(+)pi(-)pi(0) were performed for the center-of-mass energy squared s = 5 GeV2 and s = 10 GeV2, in the kinematic regions 3.0 < q(2) < 4.3 GeV2 and 5 < q(2) < 9 GeV2, respectively, with a neutral pion scattered in the forward or backward cone vertical bar cos theta(pi 0)vertical bar > 0.5 in the proton-antiproton center-of-mass frame. Results of the simulation show that the particle identification capabilities of the PANDA detector will allow to achieve a background rejection factor of 5 . 10(7) (1 . 10(7)) at low (high) q(2) for s = 5 GeV2, and of 1 . 10(8) (6 . 10(6)) at low (high) q(2) for s = 10 GeV2, while keeping the signal reconstruction efficiency at around 40%. At both energies, a clean lepton signal can be reconstructed with the expected statistics corresponding to 2 of integrated luminosity. The cross sections obtained from the simulations are used to show that a test of QCD collinear factorization can be done at the lowest order by measuring scaling laws and angular distributions. The future measurement of the signal channel cross section with PANDA will provide a new test of the perturbative QCD description of a novel class of hard exclusive reactions and will open the possibility of experimentally accessing pi N TDAs.
|
|
| 5. |
- Aliu, E., et al.
(author)
-
Long Term Observations of B2 1215+30 with VERITAS
- 2013
-
In: Astrophysical Journal. - 0004-637X .- 1538-4357. ; 779:2
-
Journal article (peer-reviewed)abstract
- We report on VERITAS observations of the BL Lac object B2 1215+30 between 2008 and 2012. During this period, the source was detected at very high energies (VHEs; E > 100 GeV) by VERITAS with a significance of 8.9s and showed clear variability on timescales larger than months. In 2011, the source was found to be in a relatively bright state and a power-law fit to the differential photon spectrum yields a spectral index of 3.6 +/- 0.4(stat) +/- 0.3(syst) withan integral flux above 200 GeV of (8.0 +/- 0.9(stat) +/- 3.2(syst)) x 10(-12) cm(-2) s(-1). No short term variability could be detected during the bright state in 2011. Multi-wavelength data were obtained contemporaneously with the VERITAS observations in 2011 and cover optical (Super-LOTIS, MDM, Swift/UVOT), X-ray (Swift/XRT), and gamma-ray (Fermi-LAT) frequencies. These were used to construct the spectral energy distribution (SED) of B2 1215+30. A one-zone leptonic model is used to model the blazar emission and the results are compared to those of MAGIC from early 2011 and other VERITAS-detected blazars. The SED can be reproduced well with model parameters typical for VHE-detected BL Lac objects.
|
|
| 6. |
- Krauss, Tobias, et al.
(author)
-
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors
- 2018
-
In: Endocrine-Related Cancer. - : BIOSCIENTIFICA LTD. - 1351-0088 .- 1479-6821. ; 25:9, s. 783-793
-
Journal article (peer-reviewed)abstract
- Pancreatic neuroendocrine tumors (PanNETs) are rare in von Hippel-Lindau disease (VHL) but cause serious morbidity and mortality. Management guidelines for VHL-PanNETs continue to be based on limited evidence, and survival data to guide surgical management are lacking. We established the European-American-Asian-VHL-PanNET-Registry to assess data for risks for metastases, survival and long-term outcomes to provide best management recommendations. Of 2330 VHL patients, 273 had a total of 484 PanNETs. Median age at diagnosis of PanNET was 35 years (range 10-75). Fifty-five (20%) patients had metastatic PanNETs. Metastatic PanNETs were significantly larger (median size 5 vs 2 cm; P < 0.001) and tumor volume doubling time (TVDT) was faster (22 vs 126 months; P = 0.001). All metastatic tumors were >= 2.8 cm. Codons 161 and 167 were hotspots for VHL germline mutations with enhanced risk for metastatic PanNETs. Multivariate prediction modeling disclosed maximum tumor diameter and TVDT as significant predictors for metastatic disease (positive and negative predictive values of 51% and 100% for diameter cut-off >= 2.8 cm, 44% and 91% for TVDT cut-off of <= 24 months). In 117 of 273 patients, PanNETs > 1.5 cm in diameter were operated. Ten-year survival was significantly longer in operated vs non-operated patients, in particular for PanNETs < 2.8 cm vs >= 2.8 cm (94% vs 85% by 10 years; P = 0.020; 80% vs 50% at 10 years; P = 0.030). This study demonstrates that patients with PanNET approaching the cut-off diameter of 2.8 cm should be operated. Mutations in exon 3, especially of codons 161/167 are at enhanced risk for metastatic PanNETs. Survival is significantly longer in operated non-metastatic VHL-PanNETs.
|
|
| 7. |
- Craik, David J., et al.
(author)
-
Nomenclature of homodetic cyclic peptides produced from ribosomal precursors : An IUPAC task group interim report
- 2016
-
In: Biopolymers. - : Wiley. - 0006-3525 .- 1097-0282. ; 106:6, s. 917-924
-
Journal article (peer-reviewed)abstract
- In 2015, an International Union of Pure and Applied Chemistry (IUPAC) Task Group was formed to develop nomenclature recommendations for homodetic cyclic peptides produced from ribosomal precursors. Delegates of the 2015 International Conference on Circular Proteins (ICCP) were presented with the strengths and weaknesses of four published approaches to homodetic cyclic peptide nomenclature, and a summary of the ensuing discussion is presented here. This interim report presents a potentially novel suggestion-the use of Cahn-Ingold-Prelog rules to specify amino acid priority in homodetic peptides for consistent numbering. Indeed, this might be the first extension of the Cahn-Ingold-Prelog rules in five decades. The authors invite interested parties to contact the corresponding author with suggestions for the improvement of the proposed nomenclature; these ideas will be discussed and considered for inclusion in the final report.
|
|
| 8. |
- Gurav, Ranjit, et al.
(author)
-
Production, characterization, and application of biochar for remediation of dyes from textile industry wastewater
- 2023
-
In: Current Developments in Bioengineering and Biotechnology. - : Elsevier BV. ; , s. 231-251
-
Book chapter (other academic/artistic)abstract
- Dyes are coloring agents widely used in the textile and leather industries. Synthetic dyes are the major contributor to global wastewater exhibiting toxic effects on humans, aquatic organisms, and the environment. The conventional decolorization treatments are less effective due to high dye concentration in wastewater, complex chemical structure, and poor biodegradability. Several strategies like physical, chemical, and biological were reported earlier for dye decolorization. However, the adsorption technique has been extensively considered from economic and ecological standpoints. Biochar, a carbonaceous material generated by pyrolyzing waste biomass has been discussed here to tackle the dye-containing wastewater. As an adsorbent, biochar has gained considerable attention owing to its underlying advantages like larger surface area, high porosity, low production cost, varied surface functional groups, easy surface modifications, exceptional hydrophobicity, and aromaticity. In this chapter, we have discussed approaches for the production, and characterization of the biochar. Furthermore, we have also considered the effect of different physicochemical properties, sorption kinetics, isotherm models, and other key factors affecting the sorption mechanism. In this perspective, an effort has been made in this chapter to explore the probability and practicability of biochar as a sorbent for removal of the textile dyes.
|
|
| 9. |
- Jadhav, S. D., et al.
(author)
-
Influence of selective laser melting process parameters on texture evolution in pure copper
- 2019
-
In: Journal of Materials Processing Technology. - : Elsevier BV. - 0924-0136 .- 1873-4774. ; 270, s. 47-58
-
Journal article (peer-reviewed)abstract
- In the present work, Crack-Free pure copper parts with relative densities exceeding 98% are processed by selective laser melting (SLM) using a high-power fiber laser. The influence of different laser scan parameters such as hatch spacing, laser power and scan speed on the texture evolution in the manufactured parts is determined. On the top surfaces, a clear interrelationship between laser scan parameters and crystallographic texture is established. This shows that the texture at the top surface can be very strong especially when a high laser power and a low scanning speed is used. However, a random texture exists in the core of the sample due to successive re-melting and altered heat gradients induced by the application of a 90° scan rotation between subsequent layers. A maximum electrical conductivity of 88% of the International Annealed Copper Standard (IACS) is achieved in the as-built state. Damage to the optical mirror of the SLM machine is observed and recommendations for sustainable up-scalability are proposed.
|
|
| 10. |
|
|
| 11. |
- Leonard, Hampton L., et al.
(author)
-
The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data
- 2023
-
In: npj Parkinson's Disease. - : Springer Science and Business Media LLC. - 2373-8057. ; 9:1
-
Journal article (peer-reviewed)abstract
- Open science and collaboration are necessary to facilitate the advancement of Parkinson’s disease (PD) research. Hackathons are collaborative events that bring together people with different skill sets and backgrounds to generate resources and creative solutions to problems. These events can be used as training and networking opportunities, thus we coordinated a virtual 3-day hackathon event, during which 49 early-career scientists from 12 countries built tools and pipelines with a focus on PD. Resources were created with the goal of helping scientists accelerate their own research by having access to the necessary code and tools. Each team was allocated one of nine different projects, each with a different goal. These included developing post-genome-wide association studies (GWAS) analysis pipelines, downstream analysis of genetic variation pipelines, and various visualization tools. Hackathons are a valuable approach to inspire creative thinking, supplement training in data science, and foster collaborative scientific relationships, which are foundational practices for early-career researchers. The resources generated can be used to accelerate research on the genetics of PD.
|
|
| 12. |
- Murray, Ewan J, et al.
(author)
-
Targeting Staphylococcus aureus Quorum Sensing with Nonpeptidic Small Molecule Inhibitors.
- 2014
-
In: Journal of medicinal chemistry. - : American Chemical Society (ACS). - 1520-4804 .- 0022-2623. ; 57:6, s. 2813-2819
-
Journal article (peer-reviewed)abstract
- A series of 3-oxo-C12-HSL, tetramic acid, and tetronic acid analogues were synthesized to gain insights into the structural requirements for quorum sensing inhibition in Staphylococcus aureus. Compounds active against agr were noncompetitive inhibitors of the autoinducing peptide (AIP) activated AgrC receptor, by altering the activation efficacy of the cognate AIP-1. They appeared to act as negative allosteric modulators and are exemplified by 3-tetradecanoyltetronic acid 17, which reduced nasal cell colonization and arthritis in a murine infection model.
|
|
| 13. |
- Oprea, Tudor I, et al.
(author)
-
Unexplored therapeutic opportunities in the human genome
- 2018
-
In: Nature Reviews Drug Discovery. - : Springer Science and Business Media LLC. - 1474-1776 .- 1474-1784. ; 17:5, s. 317-332
-
Journal article (peer-reviewed)abstract
- A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied, but potentially druggable, proteins, the US National Institutes of Health launched the Illuminating the Druggable Genome (IDG) initiative in 2014. In this article, we discuss how the systematic collection and processing of a wide array of genomic, proteomic, chemical and disease-related resource data by the IDG Knowledge Management Center have enabled the development of evidence-based criteria for tracking the target development level (TDL) of human proteins, which indicates a substantial knowledge deficit for approximately one out of three proteins in the human proteome. We then present spotlights on the TDL categories as well as key drug target classes, including G protein-coupled receptors, protein kinases and ion channels, which illustrate the nature of the unexplored opportunities for biomedical research and therapeutic development.
|
|
| 14. |
- Pham, H. D., et al.
(author)
-
Large interspaced layered potassium niobate nanosheet arrays as an ultrastable anode for potassium ion capacitor
- 2021
-
In: Energy Storage Materials. - : Elsevier B.V.. - 2405-8289 .- 2405-8297. ; 34, s. 475-482
-
Journal article (peer-reviewed)abstract
- Potassium-ion battery (KIB) is a promising technology for large-scale energy storage applications due to their low cost, theoretically high energy density and abundant resources. However, the development of KIBs is hindered by the sluggish K+ transport kinetics and the structural instability of the electrode materials during K+ intercalation/de-intercalation. In the present investigation, we have designed a potassium-ion capacitor (KIC) using layered potassium niobate (K4Nb6O17, KNO) nanosheet arrays as anode and orange-peel derived activated carbons (OPAC) as fast capacitive cathode materials. The systematic electrochemical analysis with the ex-situ characterizations demonstrates that KNO-anode exhibits highly stable layered structure with excellent reversibility during K+ insertion/de-insertion. After optimization, the fabricated KNO//OPAC delivers both a high energy density of 116 Wh/kg and high power density of 10,808 W/kg, which is significantly higher than other similar hybrid devices. The cell also displays long term cycling stability over 5000 cycles, with 87 % of capacity retention. This study highlights the utilization of layered nanosheet arrays of niobates to achieve superior K-storage for KICs, paving the way towards the development of high-performance anodes for post lithium-ion batteries. © 2020
|
|
| 15. |
- Stafford, William C., et al.
(author)
-
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
- 2018
-
In: Science Translational Medicine. - : AMER ASSOC ADVANCEMENT SCIENCE. - 1946-6234 .- 1946-6242. ; 10:428
-
Journal article (peer-reviewed)abstract
- Cancer cells adapt to their inherently increased oxidative stress through activation of the glutathione (GSH) and thioredoxin (TXN) systems. Inhibition of both of these systems effectively kills cancer cells, but such broad inhibition of antioxidant activity also kills normal cells, which is highly unwanted in a clinical setting. We therefore evaluated targeting of the TXN pathway alone and, more specifically, selective inhibition of the cytosolic selenocysteine-containing enzyme TXN reductase 1 (TXNRD1). TXNRD1 inhibitors were discovered in a large screening effort and displayed increased specificity compared to pan-TXNRD inhibitors, such as auranofin, that also inhibit the mitochondrial enzyme TXNRD2 and additional targets. For our lead compounds, TXNRD1 inhibition correlated with cancer cell cytotoxicity, and inhibitor-triggered conversion of TXNRD1 from an antioxidant to a pro-oxidant enzyme correlated with corresponding increases in cellular production of H2O2. In mice, the most specific TXNRD1 inhibitor, here described as TXNRD1 inhibitor 1 (TRi-1), impaired growth and viability of human tumor xenografts and syngeneic mouse tumors while having little mitochondrial toxicity and being better tolerated than auranofin. These results display the therapeutic anticancer potential of irreversibly targeting cytosolic TXNRD1 using small molecules and present potent and selective TXNRD1 inhibitors. Given the pronounced up-regulation of TXNRD1 in several metastatic malignancies, it seems worthwhile to further explore the potential benefit of specific irreversible TXNRD1 inhibitors for anticancer therapy.
|
|
| 16. |
- Tannergren, C., et al.
(author)
-
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
- 2023
-
In: European Journal of Pharmaceutics and Biopharmaceutics. - : Elsevier. - 0939-6411 .- 1873-3441. ; 186, s. 144-159
-
Journal article (peer-reviewed)abstract
- Colon absorption is a key determinant for successful development of extended release and colon targeted drug products. This is the first systematic evaluation of the ability to predict in vivo regional differences in absorption and the extent of colon absorption in humans using mechanistic physiologically based biopharmaceutics modeling (PBBM). A new dataset, consisting of 19 drugs with a wide range of biopharmaceutics properties and extent of colon absorption in humans, was established. Mechanistic predictions of the extent of absorption and plasma exposure after oral, or jejunal and direct colon administration were performed in GastroPlus and GI-Sim using an a priori approach. Two new colon models developed in GI-Sim, were also evaluated to assess if the prediction performance could be improved. Both GastroPlus and GI-Sim met the pre-defined criteria for accurate predictions of regional and colon absorption for high permeability drugs irrespective of formulation type, while the prediction performance was poor for low permeability drugs. For solutions, the two new GI-Sim colon models improved the colon absorption prediction performance for the low permeability drugs while maintaining the accurate prediction performance for the high permeability drugs. In contrast, the prediction performance decreased for non-solutions using the two new colon models. In conclusion, PBBM can be used with sufficient accuracy to predict regional and colon absorption in humans for high permeability drugs in candidate selection as well as early design and development of extended release or colon targeted drug products. The prediction performance of the current models needs to be improved to allow high accuracy predictions for commercial drug product applications including highly accurate predictions of the entire plasma concentration-time profiles as well as for low permeability drugs.
|
|
